Ambrx Biopharma - Stock Price History | AMAM

Historical daily share price chart and data for Ambrx Biopharma since 2022 adjusted for splits. The latest closing stock price for Ambrx Biopharma as of November 29, 2022 is 0.45.
  • The all-time high Ambrx Biopharma stock closing price was 22.53 on July 13, 2021.
  • The Ambrx Biopharma 52-week high stock price is 10.50, which is 2233.3% above the current share price.
  • The Ambrx Biopharma 52-week low stock price is 0.45, which is 0% below the current share price.
  • The average Ambrx Biopharma stock price for the last 52 weeks is 3.65.
For more information on how our historical price data is adjusted see the Stock Price Adjustment Guide.
Ambrx Biopharma Historical Annual Stock Price Data
Year Average Stock Price Year Open Year High Year Low Year Close Annual % Change
2021 14.7410 17.0500 22.5300 8.1100 9.0300 0.00%
Sector Industry Market Cap Revenue
Medical Medical - Biomedical and Genetics $0.017B $0.007B
Ambrx Biopharma Inc. is a clinical stage biopharmaceutical company using an expanded genetic code technology platform to discover and develop Engineered Precision Biologics. Ambrx Biopharma Inc. is based in SAN DIEGO.
Stock Name Country Market Cap PE Ratio
Bristol Myers Squibb (BMY) United States $168.030B 10.25
GSK (GSK) United Kingdom $69.877B 8.76
Bio-Rad Laboratories (BIO.B) United States $12.069B 28.64
QIAGEN (QGEN) Netherlands $11.099B 18.95
Ginkgo Bioworks Holdings (DNA) United States $3.589B 0.00
Myovant Sciences (MYOV) United Kingdom $2.590B 0.00
Arcus Biosciences (RCUS) United States $2.209B 33.16
Biohaven (BHVN) United States $1.050B 0.00
Emergent Biosolutions (EBS) United States $0.587B 4.62
Zymeworks (ZYME) Canada $0.486B 0.00
ADC Therapeutics SA (ADCT) Switzerland $0.260B 0.00
Enzo Biochem (ENZ) United States $0.097B 0.00
SQZ Biotechnologies (SQZ) United States $0.074B 0.00
Gelesis Holdings (GLS) United States $0.027B 0.00